BlackRock’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $454M | Sell |
|
|||||
|
2025
Q1 | $420M | Sell |
|
|||||
|
2024
Q4 | $499M | Buy |
|
|||||
|
2024
Q3 | $484M | Buy |
|
|||||
|
2024
Q2 | $374M | Sell |
|
|||||
|
2024
Q1 | $381M | Buy |
|
|||||
|
2023
Q4 | $234M | Buy |
|
|||||
|
2023
Q3 | $207M | Buy |
|
|||||
|
2023
Q2 | $125M | Buy |
|
|||||
|
2023
Q1 | $45.8M | Buy |
|
|||||
|
2022
Q4 | $48.9M | Buy |
|
|||||
|
2022
Q3 | $17.1M | Sell |
|
|||||
|
2022
Q2 | $22.1M | Buy |
|
|||||
|
2022
Q1 | $20M | Buy |
|
|||||
|
2021
Q4 | $39.6M | Buy |
|